Determinants of the use of complementary therapies by patients with cancer.
about
The use of Complementary and Alternative Medicine by cancer patientsUse of complementary/alternative therapies by women with advanced-stage breast cancerChanges in complementary and alternative medicine use across cancer treatment and relationship to stress, mood, and quality of life.Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancerMapping patterns of complementary and alternative medicine use in cancer: an explorative cross-sectional study of individuals with reported positive "exceptional" experiences.Role of traditional Islamic and Arabic plants in cancer therapy.HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionalsDoes perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey.Factors related to the use of dietary supplements by cancer survivorsHow many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.Patient-centered communication: do patients really prefer it?Complementary and alternative medicine use and quality of life in pediatric diabetes.Complementary and alternative medicine in children with type 1 diabetes mellitusDetermination of parameters affecting the use of complementary and alternative medicine in cancer patients and detection of prevalence of use.Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms.Relationship between patient satisfaction with medical doctors and the use of traditional Korean medicine in Korea.National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer.Herbal medicine use behaviour in Australian adults who experience anxiety: a descriptive study.Use of complementary and alternative medicine before and after organ removal due to urologic cancer.The evolution of mindfulness-based physical interventions in breast cancer survivorsPrevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic MalaysiaReasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review.Clinical management of pain in advanced lung cancer.Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea.Integrative oncology: a Canadian and international perspective.A systematic review of beliefs involved in the use of complementary and alternative medicine.Factors affecting the quality of life of cancer patients undergoing chemotherapy: A questionnaire study.Patient-provider communication and perspectives on smoking cessation and relapse in the oncology settingIntegrative oncology for the whole person: a multidimensional approach to cancer care.Communication in cancer care: discussing complementary and alternative medicine.Integrative oncology research in the Middle East: weaving traditional and complementary medicine in supportive care.Integrating dietary supplements into cancer care.Complementary therapy: perceptions of older people with lung or colorectal cancer.Thematic analysis of tiles painted by blood and marrow transplant patients during treatment.Using propensity score matching to evaluate the effect of complementary medicine on clinical and embryologic outcomes of in vitro fertilization.Complementary medicine and recovery from cancer: the importance of post-traumatic growth.Investigation of the trust status of the nurse-patient relationship.Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.
P2860
Q24683698-16A54C50-8327-40F3-972B-8D57F6A108BCQ24799982-3ACC1F90-D781-45B8-B3BC-AAC246582EA4Q30368095-40C7AA41-2495-46AE-9EB7-34EFDD35BF3CQ33304238-1EBC09DC-84E6-4CE5-98C7-A6DB346B572BQ33358931-EFC8CB8F-76CD-43FB-9154-1C5627DAB230Q33553079-8C4FAD56-A970-46DB-B14E-E2C7224AE07FQ33732930-000B2534-3FF8-4ECC-BE50-215F28DBEBE7Q33733423-C4864D82-3F02-4143-82C4-EE3909E178CBQ33910457-E50381AB-094E-4DF2-903C-DFAE0F3C4C9AQ33992482-26DFB3CC-8CB8-4401-8ED9-065C1AC6EBCCQ34085029-4E8A9051-0EA6-4046-869D-6222F4B3AF2CQ34226495-77367CF4-F664-41CE-B232-F082B3D21B69Q34740711-91955458-1E8E-42E3-B0D5-E1401C93B94FQ35031171-25E893BB-AADB-4EFD-B9CF-6EAA7A379577Q35251633-4C38B1F2-DCEC-4C51-AB69-5BCFD9C2E062Q35556664-3048887A-5B05-4E56-ACA3-B1FD27B0ED7EQ35607042-C52518AA-88F1-46F3-9F0C-4E76DD7A23F1Q35807368-DFF16C5A-BBFA-40BB-B807-1773758FD135Q35897402-7CF0B4C8-0970-4887-A829-A125D0249BA6Q35920323-407FEA8D-ECBB-45DA-864B-D48CCB89EB83Q36140554-B217D0F9-3707-4AE0-9B22-7F1CE87ACD02Q36246750-65CB1A7E-0FA2-4F85-A8DC-3AAB56216161Q36300811-DA6910BE-A29A-4F64-A8B8-A51110E413BFQ36311163-D0486861-3BF9-4EBB-87D5-C6FB03896978Q36327481-D5F78C2F-259D-4F12-98B7-B7C464252007Q36531132-92BA0BC0-AC47-4B17-BCF5-C0C15B58BBFFQ36860330-48081B03-78C7-4372-98E5-9E0FD8FD2B68Q36980197-DB040BFA-07B1-4558-9CD2-9C48A666B199Q37440782-ECEE6FCF-9649-4C92-B394-DEA5FB5EA803Q37455772-9066A746-83CE-4259-B0E2-C056B9532566Q37691081-6B7B4FA1-1EF0-42C8-A03C-A46A52101967Q37722096-E4106836-6C43-4365-A85F-F90A54AA91A4Q37848197-69FC7EAA-101A-47FA-B110-FC4D984F5BC8Q38084539-E844DFF9-58CC-4451-AA86-6F86AFC32F2EQ38165955-5B0368C0-2BAD-4710-A7A5-7EA1A58F3124Q38404926-A86A42EE-95CC-4705-B0C2-6DF03EDB49C6Q38734280-6796199F-53E4-41D9-B915-1A9273A6403CQ39408646-693BF2E6-9799-4249-972B-7BD44296218EQ39412113-9EC51F3A-68DF-4CCF-8D6F-9E8A2097B90AQ43135240-2EFA661B-86E0-4034-A39E-6C796BDAFBB0
P2860
Determinants of the use of complementary therapies by patients with cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Determinants of the use of complementary therapies by patients with cancer.
@en
Determinants of the use of complementary therapies by patients with cancer.
@nl
type
label
Determinants of the use of complementary therapies by patients with cancer.
@en
Determinants of the use of complementary therapies by patients with cancer.
@nl
prefLabel
Determinants of the use of complementary therapies by patients with cancer.
@en
Determinants of the use of complementary therapies by patients with cancer.
@nl
P2093
P1476
Determinants of the use of complementary therapies by patients with cancer.
@en
P2093
M Avitzour
R M Pfeffer
V Soskolne
P304
P356
10.1200/JCO.2001.19.9.2439
P407
P577
2001-05-01T00:00:00Z